Zobrazeno 1 - 10
of 20
pro vyhledávání: '"E G LOMAIA"'
Autor:
A L MELIKYAN, I N SUBORTSEVA, E A GILYAZITDINOVA, T I KOLOSHEJNOVA, E I PUSTOVAYA, E K EGOROVA, A M KOVRIGINA, A B SUDARIKOV, A O ABDULLAEV, E G LOMAIA, N T SIORDIYA, A Yu ZARITSKEY, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 23-29 (2018)
Purpose of the study. A comparative evaluation of the effectiveness of different therapeutic strategies in patients with polycythemia vera (PV) and essential thrombocythemia (ET). Materials and methods. Patients with PV or ET, diagnosed according to
Externí odkaz:
https://doaj.org/article/24b0a0e7af394e34811b114da05d6bfc
Publikováno v:
Современная онкология, Vol 13, Iss 2, Pp 8-16 (2011)
Externí odkaz:
https://doaj.org/article/1df9f7743a734884929904917253a0f6
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 5-20 (2022)
Imatinib (IM) appearance has changed approaches to chronic myeloid leukemia (CML) therapy. Second generation tyrosine kinase inhibitors (TKI) — nilotinib and dasatinib, developed soon after IM, and are already widely used in CML patients with ineff
Externí odkaz:
https://doaj.org/article/202d0cb6000e4d1db51acf67934d8ead
Autor:
E. G. Lomaia, A. Y. Zaritskey
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 67-72 (2022)
Externí odkaz:
https://doaj.org/article/9db3b5e726f9451eb3946ab4b706c401
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 4-16 (2022)
The first successful experience effective target therapy has been achieved at imatinib administration in chronic myeloid leukemia (CML) treatment. Disease early considered practically incurable, now successful controlled using little toxic conservati
Externí odkaz:
https://doaj.org/article/d220e9cc9f334285b05ca47e07bc30cf
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 40-56 (2022)
Externí odkaz:
https://doaj.org/article/1579ec1c1bde4d438fe4c4eb9c996c67
Autor:
K. V. Bogdanov, O. V. Merzlikina, Y. V. Mirolyubova, L. L. Girshova, E. G. Lomaia, A. Y. Zaritskey
Publikováno v:
Molecular Biology. 55:121-132
Publikováno v:
Молекулярная биология. 55:139-151
Dysfunction of genes that control mitosis and are responsible for the correct segregation of sister chromatids in anaphase is often accompanied by aneuploidy, which is frequently detected in leukemia. One of the components of the kinetochore complex,
Publikováno v:
Molekuliarnaia biologiia. 55(1)
Dysfunction of genes that control mitosis and are responsible for the correct segregation of sister chromatids in anaphase is often accompanied by aneuploidy, which is frequently detected in leukemia. One of the components of the kinetochore complex,
Autor:
E. G. lisina, N. T. Siordiya, P. A. Butylin, A. A. Silyutina, N. M. Matyukhina, O. M. Senderova, E. S. Fokina, V. A. Ovsepyan, E. G. Lomaia, A. Yu. Zaritskiy
Publikováno v:
Onkogematologiâ, Vol 12, Iss 3, Pp 8-16 (2017)
Introduction. JAK2V617F mutation is detected in approximately 50 % of patients with essential thrombocytosis (ET) and primary myelofibrosis (PMF). In 2013 most of the JAK2 negative patients showed mutations in the CALR gene. Diagnostic value of JAK2